Summary
The Food and Drug Administration (FDA) approved a new type of glasses called Essilor Stellest lenses meant to slow down nearsightedness in children. These glasses have shown to reduce the progression of myopia by up to 70% in children aged 6 to 12 over a two-year period.
Key Facts
- Nearsightedness, also known as myopia, makes it hard for people to see distant objects clearly.
- Myopia rates are rising, partly due to increased time indoors and screen use.
- FDA-approved Essilor Stellest lenses aim to slow myopia in children aged 6 to 12.
- Studies show these lenses slow myopia progression by about 70% over two years.
- The lenses have 11 rings that help focus light on the retina to reduce eye elongation.
- The suggested retail price for these glasses is $450.
- Most major U.S. vision insurance providers are likely to cover these lenses for eligible children.
- The only other FDA-approved myopia treatment is a type of contact lens called MiSight.
